The purpose of this study is to perform a dosimetric evaluation of amplitude-based respiratory gating for the delivery of volumetric modulated arc therapy (VMAT). We selected two types of breathing patterns, subjectively among patients with respiratory-gated treatment log files. For patients that showed consistent breathing patterns (CBP) relative to the 4D CT respiration patterns, the variability of the breath-holding position during treatment was observed within the thresholds. However, patients with inconsistent breathing patterns (IBP) show differences relative to those with CBP. The relative isodose distribution was evaluated using an EBT3 film by comparing gated delivery to static delivery, and an absolute dose measurement was performed with a 0.6 cm 3 Farmer-type ion chamber. The passing rate percentages under the 3%/3 mm gamma analysis for Patients 1, 2 and 3 were respectively 93.18%, 91.16%, and 95.46% for CBP, and 66.77%, 48.79%, and 40.36% for IBP. Under the more stringent criteria of 2%/2 mm, passing rates for Patients 1, 2 and 3 were respectively 73.05%, 67.14%, and 86.85% for CBP, and 46.53%, 32.73%, and 36.51% for IBP. The ion chamber measurements were within 3.5%, on average, of those calculated by the TPS and within 2.0%, on average, when compared to the static-point dose measurements for all cases of CBP. Inconsistent breathing patterns between 4D CT simulation and treatment may cause considerable dosimetric differences. Therefore, patient training is important to maintain consistent breathing amplitude during CT scan acquisition and treatment delivery.
Introduction
Advanced radiotherapy techniques, such as intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) which evolved from intensity modulated radiation therapy, have enhanced treatment outcomes by delivering a conformal radiation dose to the targeted tumors while sparing healthy surrounding tissues from radiation. 1) However, this delivery technique is difficult to apply in the thoracic and abdominal regions because there is limited target delineation accuracy resulting from motion artifacts produced during imaging and increased dose uncertainties that arise from irradiating a moving target with a large number of small fields. Hence, the motion of the target that is due to respiration is a significant and challenging problem for the delivery of radiation therapy.
Gated volumetric modulated arc therapy provides an opportunity to account for respiration-induced motion of the targets.
In order to achieve the desired dose distribution during beam delivery of gated VMAT, the dose rate, gantry rotation speed, and multileaf collimator (MLC) leaf moving speed are not only modulated but also intentionally interrupted to synchronize with the patient's respiratory cycle. The geometric accuracy of gated VMAT has been investigated using a dynamic phantom, and the dosimetric accuracy of gated VMAT has shown in a preclinical study that gated VMAT delivery is robust and dosimetrically accurate in a non-clinically released environment. [2] [3] [4] These studies investigated the dosimetric fidelity of gated VMAT delivery using log file-based dose reconstruction and ion chamber array measurements. 5, 6) In a study performed by Qian et al., artificial regular sinusoidal motion, not a real patents' respiratory motion, was used to verify the experiments, which obviously provides results that are different from an actual clinical situation. As shown in a recent study, the interplay effect has a limited impact on gated RapidArc therapy when evaluated with a linear phantom. 7) On the other hand, reports on the dosimetric evaluation of gated VMAT under actual clinical conditions that focus on amplitude-based respiratory gating for delivery are scarce.
This study uses respiratory data acquired from three clinical patients to investigate the variation in the breathing patterns between a 4D CT simulation and during treatment, and to evaluate the dosimetric influence of amplitude-based respiratory gating for the delivery of VMAT using a one-dimensional respiratory motion phantom under actual clinical conditions.
Materials and Methods

RapidArc with ClinacⓇ iX linear accelerator and respiratory motion phantom
This study used a Varian ClinacⓇ iX linear accelerator with RapidArc capabilities and a real-time position management (RPM) system for respiratory gating. RapidArc is a novel planning and delivery technique used in volumetric modulated arc therapy, and it was introduced and commercialized based on Karl Otto's concept of volumetric arc therapy. 8) The RPM system tracks the respiratory cycles of the patient using a reflective plastic box placed on the patient's abdominal surface.
To evaluate the dosimetric influence during gated VMAT delivery, we used a respiratory motion phantom (Quasar, Modus
Medical Devices, Inc., London, ON, Canada), as shown in We used a dedicated breathing control program. In this system, the patient observes his/her own breathing trace through a goggle monitor screen and follows programmed sinusoidal oscillations that can be adjusted in terms of the frequency. This system can be allowed the patient to familiarize him or herself with a breathing pattern so that he/she can evaluate his or her ability to achieve reproducible respiratory signals. Tables 1 and 2 .
To evaluate the dosimetric influence of the plans for selected cases, a 4D CT of the motion phantom was scanned us- ing a GE LightSpeed 16-slice CT scanner that was integrated with the Varian real-time position management (RPM) system.
The phantom was scanned with 1.25 mm slice thickness in order to capture objects at the highest resolution. The execution of the 4D CT simulation on the phantom was based on the selected patient's respiratory trace data sets.
Once the scan was completed, reconstructed CT images and RPM chest wall motion data were sent to a GE Advantage (General Electric Company, Waukesha, WI) computer for sorting. After the phases of all patients image set were sorted from 40% to 60% for use in gated VMAT, the image sets were forwarded to the treatment planning system to generate the treatment plan.
We analyzed the breathing patterns that are caused by programmable motion control software during patient treatment and compared them to those of the 4D CT simulation. Fig. 2 shows the respiratory curves for Patient 1 corresponding to all fractions of the treatment. Fig. 3 shows the analyzed patients breath-holding position from marker signals for entire treatment fractions. We selected two types of breathing patterns subjectively from the log files of the gated VMAT of the patients. For patients with a consistent breathing pattern (CBP)
relative to the 4D CT respiration data, the variability of the breath-holding position during treatment was observed within thresholds defined from 4D CT image sets for phases of 40% and 50%. Since all patients image set were sorted from 40% to 60% for use in gated VMAT, we should know the marker position at phase of 40% and 50% from 4D CT image set.
However, for inconsistent breathing patterns (IBP), the variability of the breath-holding position during treatment deviated from the thresholds. The actual patients were successfully treated without problems associated with baseline shift. But, there was a change in the respiratory amplitude size between the inter-fractional treatments. In this study, we have investigated the dosimetric difference between the two cases under assumed that delivery deviated from the thresholds as IBP.
The error bars represent the variation of amplitude position during gated VMAT. Table 3 
Treatment planning
The treatment was planned using the Eclipse treatment plan- 
Gafchromic EBT3
The delivery and distribution of the doses were verified us- which could be considered to be uniform.
Dose delivery and measurements
The EBT3 films were cut to 15 by 6.5 cm in size to fit the cassette, and a personal computer was used to communicate with the motion phantom using a software application that downloads respiratory waveforms of patients to the phantom, thereby simulating the breathing. The treatment was delivered to the phantom on two separate occasions: first it was delivered using a gated VMAT, and then reference stationary measurements were taken. The results of both were then compared.
The absolute doses were measured with a 0.6 cm 3 Farmertype ion chamber (PTW Type 30013). The ion chamber was placed in a movable insert of the motion phantom, and the measurements for the stationary phantom without beam gating were used as a standard for comparison against other measurements. Three measurements were taken for all configurations of the ion chamber, and the average was used to present the results in this study.
The gamma (γ) index that was proposed by Low et al. to The isodose levels shown are 90%, 70%, 50%, and 30%, and the gamma pass-rate maps show a 3% dose difference, with a 3 mm distance-to-agreement criteria.
quantitatively evaluate the dose distributions was used to perform a quantitative comparison of the dose distributions. 
Results
We evaluated the dose accuracy of the gated VMAT on the linear phantom by comparing the isodose distributions, gamma statistics, and ion chamber measurements.
Film measurement
A film-to-film comparison has an advantage in that it isolates the effects of gating by not having to consider either po- 
Ion chamber measurements
The ion chamber measurements of the gated deliveries were compared to the point doses calculated with the TPS and to the static point dose measurements, and the results are summarized in Table 4 . The ion chamber measurements were within 3.5%, on average, of the values calculated using TPS and within 2.0%, on average, when compared to the static point dose measurements for all cases of CBP. For the IBP, we found that the dose discrepancies were more than twice as large as those measured in CBP, as compared to the planned dose. In the case of Patient 3, the percentage difference in dose from the ion chamber measurements can be seen to have a significant difference.
Discussion
The patient always moves to some extent during treatment, and this affects the quality of the delivered dose. Although our studies were based on a phantom that achieved realistic patient motion in one dimension, such is not perfectly identical to organ movement yet the results of the measurements are valid. There are several sources of uncertainty in the film analysis such as the response at high-dose levels, sensitivity to scanner orientation and post-irradiation coloration, energy and dose rate dependence, and orientation dependence with respect to the side of the film. In the study performed by Casanova Borca et al., most of the characteristics of the EBT3 film were found to be similar to those of the EBT2 film.
11) A study of the colorization process revealed fast stabilization of the film that occurred within two hours. The color variation for unit doses has also been investigated, indicating that the red channel has a greater response for up to 10 Gy while the green channel is preferable at higher dose levels. The analysis of the variation in the energy levels and dose rates shows no significant differences between the two films. The EBT3 film shows a different response that depends on whether the film has a portrait or landscape orientation, but negligible differences where found when the film as placed face up or face down. In addition, the Eclipse AAA algorithm is not very accurate for regions of electronic disequilibrium, such as at the field edges. 12) This could also explain why some of discrepancies are seen in the film/TPS comparison.
Only two fractions for each patient were studied, and the influence of the entire treatment fractionation was not included.
However, as the results of the study showed, the results of other adapted patient plans could be intuitively anticipated.
Therefore such circumstances should not have an influence on our conclusions.
Conclusion
We have investigated a dosimetric evaluation of gated VMAT using a phantom that achieved realistic patient motion in one dimension. The results of this study show that variations in the amplitudes of patient breathing during treatment arise from inconsistent breathing patterns, and these variations are of great clinical significance. Therefore, an effort to maintain consistent patient breathing patterns is important in order to increase the reproducibility of the patterns, to produce the same conditions as those during CT scan acquisition and treatment delivery.
Care must be taken when monitoring a patient's respiratory pattern to determine whether or not the patient achieves reproducible respiratory signals that generate the same conditions as those during CT scan acquisition and treatment delivery.
